🇺🇸 Inactivated Influenza Vaccine in United States

32 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 32

Most-reported reactions

1. Respiratory Failure — 4 reports (12.5%)
2. Rhabdomyolysis — 4 reports (12.5%)
3. Coordination Abnormal — 3 reports (9.38%)
4. Diabetic Neuropathy — 3 reports (9.38%)
5. Drug Interaction — 3 reports (9.38%)
6. Guillain-Barre Syndrome — 3 reports (9.38%)
7. Infection — 3 reports (9.38%)
8. Leukocytosis — 3 reports (9.38%)
9. Mobility Decreased — 3 reports (9.38%)
10. Pain — 3 reports (9.38%)

Source database →

Frequently asked questions

Is Inactivated Influenza Vaccine approved in United States?

Inactivated Influenza Vaccine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Inactivated Influenza Vaccine in United States?

St. Louis University is the originator. The local marketing authorisation holder may differ — check the official source linked above.